|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 2 | Management of hyperglycemia in type 2 diabetes:a patient-centered approach:position statement of the American Diabetes Association(ADA)and the European Association for the Study of Diabetes(EASD)显示文摘 | INZUCCHI S E BERGENSTAL R M BUSE J B | 2012 | Diabetes Care2012，35，6： | 1 |
| 3 | Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin Al C levels in T1 Dexchange clinic registry participants显示文摘 | Miller K M Beck R Bergenstal R | 2013 | Diabetes Care2013，36，7： | 1 |
| 4 | Examination of cardiovascular outcomes with alogliptin versus standard of care in patients with type-2 diabetes mellitus and acute coronary syndrome (EXAMINE):a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type-2 diabetes with acute coronary syndrome显示文摘 | WHITE W B BAKRIS G L BERGENSTAL R M | 2011 | Am Heart J2011，162，4： | 1 |
| 5 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 1 |
| 6 | Management of hyperglycemia in type 2 diabetes,2015:a patient-centered approach:update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes显示文摘 | Inzucchi S E Bergenstal R M Buse J B | 2015 | Diabetes Care2015，38，1： | 1 |
| 7 | Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes显示文摘 | Bergenstal R M Tamborlane W V Ahmann A | 2010 | N Engl J Med2010，363，4： | 1 |
| 8 | Exenatide once weekly improved glycaemic control,cardiometabolic risk factors and a composite index of an Hb A1c<7%,without weight gain or hypoglycaemia,over52 weeks显示文摘 | Bergenstal R M Li Y Porter T K | 2013 | Diabetes Obesity&Metabolism2013，15，3： | 1 |
| 9 | Management of hyperglycemia in type 2 diabetes: a patient-centered approach position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzueehi S E Bergenstal R M Buse J B | 2012 | Diabetes Care2012，35，6： | 1 |
| 10 | Management of hyperglycemia in type 2 diabetes:a patient-centered approach posit ion st atement of t he A mer ica n Diabetes Associat ion(ADA)and the European Association for the Study of Diabetes(EASD)显示文摘 | In z ucchi SE Bergenst al R M Buse J B | 2012 | Diabetes Care2012，35，6： | 1 |
| 11 | Use of twicedaily exenatide in basal insulin-treated patients with type 2diabetes:a randomized,controlled trial显示文摘 | Buse J B Bergenstal R M Glass L C | 2011 | Ann Intern Med2011，154，2： | 1 |
| 12 | Management of hyperglycemia in type 2 diabetes,2015:a patient-centered approach:update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes显示文摘 | Inzucchi S E Bergenstal R M Buse J B | 2015 | Diabetes Care2015，38，1： | 1 |
| 13 | Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2) : a randomised trial显示文摘 | BERGENSTAL R M WYSHAM C MACCONELL L | 2010 | Lancet2010，376，9739： | 1 |
| 14 | Clinieal application of ineretin-based therapy: therapeutic: potential, patient selection, and clinical use显示文摘 | Kendall D M Cuddihy R M Bergenstal R M | 2009 | Am J Med2009，122，6： | 1 |
| 15 | The association between symptomatic, severe hypoglycaemia and mortality in type2 diabetes:retrospective epidemiological a- nalysis of the ACCORD study显示文摘 | BONDS D E MILLER M E BERGENSTAL R M | 2010 | BMJ2010，340，： | 1 |
| 16 | Effi- cacy and safety of exenatide once weekly versus sitagliptin or pio-glitazone as an adjunct to metfomlin for treatment of type 2 diabe- tes (DURATION-2) : A randomised trial显示文摘 | BERGENSTAL R M WYSHAM C MACCONELL L | 2010 | Lancet2010，376，9739： | 1 |
| 17 | New insulin glargine300 U/ml compared with glargine 100 U/ml in insulin-naive peoplewith type 2 diabetes on oral glucose-lowering drugs : a randomizedcontrolled trial (EDITION 3)显示文摘 | Bolli G B Riddle M C Bergenstal R M | 2015 | Diabetes Obes Metab2015，17，4： | 1 |
| 18 | The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference显示文摘 | BERGENSTAL R M GAVIN J R 3rd | 2005 | Am J Med2005，118，： | 1 |
| 19 | Efficacy and safety of taspoglutide versus sitagliptin for type 2 diabetes mellitus (T-Emerge 4 Trial) 显示文摘 | BERGENSTAL R M FORTI A CHIASSON J L | 2012 | Diabetes Ther2012，3，1： | 1 |
| 20 | Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabe- tes : A randomized, controlled trial 显示文摘 | BUSE J B BERGENSTAL R M GLASS L C | 2011 | Ann Intern Med2011，154，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员